$24.44
-0.02-0.08%
At close: Feb 13, 4:00 PM EST
$24.58
0.140.57%
After Hours: Feb 13, 9:29 AM EST
Comments
Loading...
Fresenius Medical Care AG Analyst Ratings
FMSNYSE
Earnings: Q4 2025 Earnings in 8 days from now on Tue Feb 24th, before the market open
Fresenius Medical Care Analyst Ratings and Price Targets | NYSE:FMS | Benzinga
Fresenius Medical Care AG has a consensus price target of $26 based on the ratings of 4 analysts. The high is $30 issued by Truist Securities on May 12, 2025. The low is $22 issued by Truist Securities on February 23, 2023. The 3 most-recent analyst ratings were released by Truist Securities on May 12, 2025, January 6, 2025, and October 7, 2024, respectively. With an average price target of $26 between Truist Securities, there's an implied 5.78% upside for Fresenius Medical Care AG from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Truist Securities
Truist Securities
1calculated from analyst ratings
Analyst Ratings for Fresenius Medical Care
FAQ
What is the target price for Fresenius Medical Care (FMS) stock?
The latest price target for Fresenius Medical Care (NYSE:FMS) was reported by UBS on September 2, 2025. The analyst firm set a price target for $0.00 expecting FMS to fall to within 12 months (a possible -100.00% downside). 2 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Fresenius Medical Care (FMS)?
The latest analyst rating for Fresenius Medical Care (NYSE:FMS) was provided by UBS, and Fresenius Medical Care downgraded their sell rating.
When was the last upgrade for Fresenius Medical Care (FMS)?
The last upgrade for Fresenius Medical Care AG happened on November 24, 2023 when HSBC raised their price target to N/A. HSBC previously had a reduce for Fresenius Medical Care AG.
When was the last downgrade for Fresenius Medical Care (FMS)?
The last downgrade for Fresenius Medical Care AG happened on September 2, 2025 when UBS changed their price target from N/A to N/A for Fresenius Medical Care AG.
When is the next analyst rating going to be posted or updated for Fresenius Medical Care (FMS)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Fresenius Medical Care, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Fresenius Medical Care was filed on September 2, 2025 so you should expect the next rating to be made available sometime around September 2, 2026.
Is the Analyst Rating Fresenius Medical Care (FMS) correct?
While ratings are subjective and will change, the latest Fresenius Medical Care (FMS) rating was a downgraded with a price target of $0.00 to $0.00. The current price Fresenius Medical Care (FMS) is trading at is $24.58, which is out of the analyst’s predicted range.
